Align Technology, Inc. (NASDAQ: ALGN - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $157.87 and traded as high as $171.15. Align Technology shares last traded at $166.87, with a volume of 933,692 shares changing hands. Analyst Ratings Changes A

Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Align Technology (ALGN) or West Pharmaceutical Services (WST). But which of these two stocks is more attractive to value investors?

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Align Technology (ALGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TEMPE, Ariz.--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2026 financial results on Wednesday, April 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and w.

Pallas Capital Advisors LLC raised its holdings in Align Technology, Inc. (NASDAQ: ALGN) by 108.9% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 8,034 shares of the medical equipment provider's stock after acquiring an additional 4,188 shares during the quarter. Pallas Capital

Align Technology's growth surges on record aligner demand and DSO expansion, while Hologic's near-complete buyout leaves little upside for investors.

Maridea Wealth Management LLC boosted its stake in shares of Align Technology, Inc. (NASDAQ: ALGN) by 125.4% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 6,193 shares of the medical equipment provider's stock after buying an additional

Align Technology, Inc. (NASDAQ: ALGN - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen research firms that are presently covering the stock, MarketBeat reports. Seven analysts have rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12 month target

Investors interested in stocks from the Medical - Dental Supplies sector have probably already heard of Align Technology (ALGN) and West Pharmaceutical Services (WST). But which of these two companies is the best option for those looking for undervalued stocks?